Latest news
Sail Biomedicines - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 05:56:36 GMTGoodwin Guides Sail Biomedicines In Strategic Collaboration To Advance In Vivo CAR-T Medicines - MondaqMondaq · Mon, 03 Aug 2026 06:29:34 GMTJohnson & Johnson Secures $2.58 Billion Option To Acquire Sail Biomedicines - Pulse 2.0Pulse 2.0 · Sun, 02 Aug 2026 13:15:20 GMTJohnson & Johnson Backs In Vivo CAR-T With a Three-Part Deal for Sail Biomedicines - biobuzz.iobiobuzz.io · Fri, 31 Jul 2026 18:28:31 GMTJ&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 31 Jul 2026 07:00:00 GMTJ&J secures $2.58bn option to buy in vivo CAR T firm Sail Biomedicines - BioXconomyBioXconomy · Fri, 31 Jul 2026 07:00:00 GMTJohnson & Johnson gains exclusive option to acquire Sail Bio - The Pharma LetterThe Pharma Letter · Fri, 31 Jul 2026 07:00:00 GMTJ&J lowers 2026 profit forecast - NewswavNewswav · Fri, 31 Jul 2026 02:42:32 GMT